ASPECTS OF THE FEATURES OF CHALLENGES OF ANTIFUNGAL RESISTANCE, ISSUES OF MYCOTOXICOLOGY, MYCOECOLOGY AND PROBLEMS OF BIOLOGICAL SAFETY IN GENERAL
DOI:
https://doi.org/10.52340/jecm.2025.04.14Keywords:
Antifungal resistance, mycotoxicology, mycoecology, biological safetyAbstract
The article reviews key aspects related to Candida fungi, including their clinical significance, mechanisms of antifungal resistance, mycotoxicological risks, ecological prevalence, and biosafety challenges. Candida fungi are an important group of opportunistic pathogens that can cause a wide range of infections in immunocompromised hosts. Studying the mechanisms of Candida adaptation to various environments and their ability to form biofilms is important for understanding the pathogenesis and developing effective therapeutic strategies. In addition, antifungal resistance is becoming an increasingly pressing public health problem requiring new approaches in antimicrobial therapy. Studies of mycotoxicological aspects indicate the potential toxicity of some Candida metabolites and the need for their monitoring.
Downloads
References
Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol. 2001;9(7):327–35.
Sulashvili N, Gorgaslidze N, Beglaryan M, Gabunia L, Alavidze N, Abuladze N, Giorgobiani M, Sulashvili M. The scientific discourse of key issue aspects of features of Candida problems, antifungal drugs resistance concerns, mycotoxicology issues, mycoecology, biosafety risks and emerging solutions. Mod Sci Method. 2025;(9). https://ojs.publisher.agency/index.php/MSM/article/view/5423
Cowen LE, Noble SM. Antifungal drug resistance: mechanisms and epidemiology. Annu Rev Microbiol. 2009;63:377–94.
Denning DW, Hope WW. Therapy for fungal diseases: opportunities and priorities. Trends Microbiol. 2010;18(5):195–204.
Fanning S, Cowen LE. Resistance in Candida albicans. Curr Opin Microbiol. 2014;18:113–9.
Gullo A. Invasive fungal infections: the challenge continues. Drugs. 2009;69(1):65–73.
Sulashvili N, Davitashvili M, Gorgaslidze N, Gabunia L, Beglaryan M, Alavidze N, Sulashvili M. The scientific discussion of some issues of features and challenges of using of CAR-T cells in immunotherapy. Georgian Sci. 2024;6(4):263–90. doi:10.52340/gs.2024.06.04.24
Sulashvili N, Gorgaslidze N, Gabunia L, Giorgobiani M, Ratiani L. Manifestation of the particularities of the usage features of monoclonal antibodies in various pharmacotherapeutic applications. Exp Clin Med Georgia. 2023;(4):52–7. doi:10.52340/jecm.2023.04.14
Sulashvili N, Gorgaslidze N, Gabunia L. Manifestation of the particularities of some key issue aspects of new immunotherapy challenges and perspectives by CAR-T cell therapy. Exp Clin Med Georgia. 2024;(4):119–21. doi:10.52340/jecm.2024.04.32
Downloads
Published
How to Cite
Issue
Section
